| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
5 companies
Atlas Venture Fund Xi, L.P. serves as a 10% Owner at DAWN and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 5 buys and 38 sells. Those positions are worth an estimated $54.2M at current prices.
Historically, Atlas Venture Fund Xi, L.P.'s trades have earned a middling insider score of 53/100 across 19 rated trades. Over a 12-month horizon, 68.4% of those trades were profitable, with an average 12-month return of +18.5%.
The biggest single holding is DYN (~$21.8M) as 10% Owner. The recent filings there lean toward selling, a net 1,818,779 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | 10% Owner | Buy | 60,000 | $18.00 | $1,080,000.00 | +8.0% | -42.0% | +70.9% | |
| Feb 28, 2024 | DYN Dyne Therapeutics, Inc. | 10% Owner | Sell | 807,838 | $24.30 | $19,626,902.97 | -48.3% | +20.1% | -47.3% | |
| Feb 23, 2024 | DYN Dyne Therapeutics, Inc. | 10% Owner | Sell | 500,789 | $22.64 | $11,339,780.44 | -35.2% | +37.1% | -38.5% | |
| Feb 20, 2024 | DYN Dyne Therapeutics, Inc. | 10% Owner | Sell | 510,152 | $23.26 | $11,867,292.26 | -7.0% | +55.6% | -39.2% | |
| Feb 8, 2024 | XLO Xilio Therapeutics, Inc. | 10% Owner | Sell | 1,000 | $0.64 | $640.00 | -0.1% | +101.7% | +13.3% | |
| Jan 12, 2024 | XLO Xilio Therapeutics, Inc. | 10% Owner | Sell | 4,235 | $0.85 | $3,600.45 | -0.6% | +83.0% | +48.0% | |
| Dec 14, 2021 | IMA Imagenebio, Inc. | 10% Owner | Sell | 26,278 | $14.67 | $385,571.87 | -2.1% | -59.2% | -80.1% | |
| Oct 26, 2021 | XLO Xilio Therapeutics, Inc. | 10% Owner | Buy | 187,500 | $16.00 | $3,000,000.00 | +34.2% | -12.5% | -86.4% | |
| Jun 1, 2021 | DAWN Day One Biopharmaceuticals, Inc. | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | -200.0% | +28.7% | -69.2% | |
| Mar 30, 2021 | IMA Imagenebio, Inc. | 10% Owner | Buy | 125,000 | $16.00 | $2,000,000.00 | +16.7% | -44.1% | -76.1% |